• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1999 Fiscal Year Final Research Report Summary

The molecular biological analysis for the release mechanism of endothelial-derived vasoactre substances.

Research Project

Project/Area Number 10670631
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionThe University of Tokyo

Principal Investigator

SHIN Wee Soo  Instructor, Health Service Center, 保健管理センター, 助手 (10211971)

Co-Investigator(Kenkyū-buntansha) TOYO-OKA Teruhiko  Professor of Medicine and Director of Health Service Center, 医学部, 教授 (00146151)
Project Period (FY) 1998 – 1999
KeywordsVascular endothelium / nitre oxide / IPィイD23ィエD2 / intracellular calcium ions / antisense aligouucleotides
Research Abstract

1. Anti, IP3 receptor antibody : made from C-terminal of type I IP3 receptor, showing single band on the Western Blotting and immunologically positive for bovine endothelial cells and rat cerebellum (membrane fraction)
2. Effects of anti-IP3 receptor Ab on [CaィイD12+ィエD1]ィイD2iィエD2 ATP-induced CaィイD12+ィエD1 elevation was inhibited by anti IP3 receptor antibody dose-dependently. It inhibited both initial peak and sustained phase of CaィイD12+ィエD1 elevation.
3. Effects of NOS inhibitor l-NMMA : Cotreatment of l-NMMA with anti IP3 receptor antibody is not enough for complete block of IPィイD23ィエD2 induced CaィイD12+ィエD1 release, revealing the autocrine action of NO. These results have shown that this method can analyze each signal transduction step in endothelial cells using intracellular calcium ions as a biological marker and also can apply more precise mechanism of vasoactive substances such as NO or endothelin.
4. Transfection experiments : As a result of transfection of a marker gene (LacZ) into smooth muscle cell line, Lipofection is superior to HVJ-liposome method or to plasmid alone. Currently, antisense ODNs to NOS are transfected into VSMC or EC and [CaィイD12+ィエD1]ィイD2iィエD2 are measured.

  • Research Products

    (8 results)

All Other

All Publications (8 results)

  • [Publications] Wang Y., Chen J., Wang Y., et al.: "Not type-3, but type-2 inositol trisphosphate (IP_3) receptors is crucial for IP_3 induced Ca^<2+> release and proliferation in vascular smooth muscle cells"Circulation. 100. I209 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Wang Y., Chen J., Wang Y., et al.: "Down-regulation of type-1 IP_3R and functional IICR in VSMC by basal release of nitric oxide from endothelial cells"Circulation. 100. I623 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kawaguchi H., Shin WS., Okai Y., et al.: "Apoptolic cell death in acute myocardial injury induced by isoproterenol is mediated by nitric oxide"J. Cardiovasc. Pharmacol.. 34. S25-S28 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kawada T., Shin WS., Nakatsuru Y., et al.: "Precise identification of gene products in hearts after in vivo gene transfection using Sendai virus-coated proteoliposome"Biochem. Biophys. Res. Commun.. 259. 408-413 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kawada T., Nakatsuru Y., Sakamoto A., et al.: "Strain- and age-dependent loss of sarcoglycan complex in cardiomyopathic hamster hearts and its re-expression by 8 salcoglycan gene transfer in vivo"FEBS Lett.. 458. 405-408 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Suzuki J., Shimamoto R., Nishikawa J., et al.: "Morphological onset and early diagnosis in aperal hypertrophic cardio-myopathy: A long terminalysis with unclear magnetic resonance imaging"J. Am. Cott. Cardiol..

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 申 偉秀、豊岡 照彦: "Ca拮抗薬のすべて(第二版)分担分:Ca拮抗薬の血管平滑筋に対する作用"先端医学社. 9/447 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 申 偉秀: "薬物障害ガイド:分担分:血管*腫"南山堂. 3/ (1999)

    • Description
      「研究成果報告書概要(和文)」より

URL: 

Published: 2001-10-23  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi